Allergy to pholcodine: first case documented by oral challenge.
Codreanu
F
F
Department of Internal Medicine, Clinical Immunology and Allergology University Hospital, 29 av de Lattre de Tassigny 54035 Nancy, France.
Morisset
M
M
Kanny
G
G
Moneret-Vautrin
D A
DA
D000284:Administration, Oral; D000328:Adult; D000799:Angioedema / Q000139:chemically induced; D000996:Antitussive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003061:Codeine / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000209:etiology*; D005260:Female; D006801:Humans; D007818:Laryngeal Diseases / Q000139:chemically induced; D009025:Morpholines / Q000008:administration & dosage / Q000009:adverse effects*; D010612:Pharyngitis / Q000188:drug therapy; D012882:Skin Tests
D000996:Antitussive Agents; D009025:Morpholines; C008872:pholcodine; D003061:Codeine